Mayo Clinic Q&A: What is a liquid biopsy?

August 10, 2018 by From Mayo Clinic News Network, Mayo Clinic News Network

Dear Mayo Clinic: What is a liquid biopsy? Can it be used in place of a tumor biopsy to find cancer?

A: A liquid biopsy involves examining cancer-related material (like DNA) from a blood sample. At this time, a liquid biopsy can't replace a tumor biopsy. But researchers are studying the benefits of, and best uses for, liquid biopsies. They show promise in guiding individualized approaches to cancer management. Eventually, liquid biopsies also may be able to help screen for some forms of cancer.

Cancer is characterized by cell changes, including mutations and other genetic alterations, which lead to the development of abnormal cells that divide uncontrollably. Identifying the specific alterations associated with a person's cancer can help health care providers determine the best treatment for that individual.

The diagnosis and characterization of cancers require tissue sampling through a tumor biopsy. This involves taking a sample of the cancerous tissue or cells through an invasive procedure and examining the sample in a lab. Tumor biopsies offer a wealth of information for health care providers to use when developing a cancer treatment plan.

But biopsies have limitations. First, a tumor changes over time as it grows, spreads (metastasizes) and is exposed to anti-cancer medications. That means tumor biopsies taken when the disease is first diagnosed may not reflect the current state of the cancer. Second, repeating biopsies to get updated information about cancer is invasive and associated with potential complications, including pain, infection and bleeding. Third, cancer cells that spread to different areas of the body may differ somewhat from the cancer at the site where it started. As a result, a tumor biopsy from one part of the body is unlikely to adequately represent cancer throughout the body.

Going through multiple procedures is not practical and can be difficult on patients. Liquid biopsies may offer an alternative for monitoring cancer over time that is less expensive and less invasive, and thus easier to repeat, than . In addition, genetic material from all sites of disease is released into the circulation, so blood sampling may provide a real-time, representative view of the evolving cancer throughout the body.

Information gained from liquid biopsies should help health care providers select the best therapy for a patient at a given time in the course of metastatic disease. Blood-based monitoring also may indicate the need to switch to a different treatment regimen before changes appear on an imaging exam. In the setting of early-stage cancer, periodically checking the blood for cancer signals after potentially curative therapy could identify patients who are at risk for recurrence. Some research suggests that liquid biopsies may be able to detect when cancer returns long before a reappears. That could lead to earlier intervention and improved survival.

With continued research and technological improvements, the ultimately may become a tool for cancer screening. Early detection is expected to improve cancer-related outcomes. This is particularly important for those cancers currently without effective methods of screening and prevention.

Although liquid biopsies still are being researched, the potential they offer to provide a new way to monitor the presence of cancer, track cancer's response to treatment and watch for a recurrence of cancer using a blood test could be a significant step forward in care.

Explore further: IASLC issues statement paper on liquid biopsy for lung cancer

shares

Related Stories

IASLC issues statement paper on liquid biopsy for lung cancer

June 21, 2018
The lungs can be a difficult organ to biopsy with a needle, so the promise of identifying lung cancer through a blood-based biopsy has lung cancer experts and patients optimistic. Knowing how and when to use a liquid biopsy ...

Liquid biopsies offer hope for earlier treatment, better tracking of ovarian cancer

July 20, 2016
Researchers at the Mayo Clinic Center for Individualized Medicine have found a promising new way to monitor and treat recurrence of ovarian cancer—a hard-to-detect disease that claims many lives. New research from George ...

'Liquid biopsy' can help predict outcomes in metastatic triple-negative breast cancer

February 16, 2018
A clinically relevant "liquid biopsy" test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer (TNBC), according to new research published ...

Simple blood tests can help detect, target cancer: study

June 4, 2016
Blood samples can be just as effective as invasive tissue biopsies in monitoring cancer and can help doctors better prescribe treatment, a study revealed Saturday.

Liquid biopsies—a non-invasive look at treatment response

June 30, 2017
A new study, to be presented at the ESMO 19th World Congress on Gastrointestinal Cancer, shows that so-called "liquid biopsies", blood tests that detect circulating tumour DNA (ctDNA), may not only sound an early alert that ...

'Liquid biopsy' may show whether cancer drugs are working

July 13, 2016
(HealthDay)—Researchers have developed a blood test that might allow doctors to know quickly whether a cancer drug is working.

Recommended for you

Week 34 of pregnancy reduces breast cancer risk: study

October 23, 2018
Women's bodies undergo a "striking" change during a specific week of pregnancy that can significantly reduce their risk of developing breast cancer later in life, scientists said Tuesday.

New kind of compound shows early promise against prostate cancer

October 23, 2018
A new type of molecule blocks the action of genes that drive the growth of therapy-resistant prostate cancer, a new study finds.

New combination treatment flips the switch on melanoma cells

October 23, 2018
Think of the protein BH3 like a finger that turns off a cancer cell survival switch. The problem is that most cancer cells have found ways to remove this "finger—commonly, by breaking the action of a gene called p53 that ...

Desperate & duped? GoFundMe means big bucks for dubious care

October 23, 2018
People seeking dubious, potentially harmful treatment for cancer and other ailments raised nearly $7 million over two years from crowdfunding sites, a study found.

Marker found for condition that causes numerous tumors

October 23, 2018
UT Southwestern researchers have made a major advance in uncovering the biology of how thousands of disfiguring skin tumors occur in patients troubled by a genetic disorder called neurofibromatosis type 1 (NF1). This scientific ...

Urban and rural rates of childhood cancer survival the same, study finds

October 23, 2018
Childhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new study from the Brown School at Washington University in St. Louis.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.